US · Healthcare · Medical Instruments & Supplies
EPS came in at 0.36 against a street estimate of 0.31 — a beat of 16.1%.
Analysts rate Envista Holdings Corp a hold (3 buy, 10 hold, 1 sell out of 14) with an average price target of $29.43.
| Fund | Stake |
|---|---|
| BlackRock Inc | 10.97% |
| Ariel Investments, LLC | 6.68% |
| Dimensional Fund Advisors, Inc. | 6.01% |
| Morgan Stanley - Brokerage Accounts | 5.40% |
| Vanguard Portfolio Management, LLC | 4.65% |
| Vanguard Capital Management, LLC | 4.50% |
| Franklin Resources Inc | 4.24% |
| Gates Capital Management Inc | 3.30% |
| Document | Date |
|---|---|
| Board / officer change · Q2 2026 | 2026-06-03 |
| Shareholder vote results · Q2 2026 | 2026-05-21 |
| Quarterly report · Q2 2026 | 2026-05-06 |
| Results announced · Q2 2026 | 2026-05-06 |
| Proxy statement · Q4 2025 | 2026-04-07 |
| Annual report FY2025 | 2026-02-12 |
| Results announced · Q1 2026 | 2026-02-05 |
| Quarterly report · Q3 2025 | 2025-10-30 |
Readable in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Envista Holdings Corp — free to start.
Google PlayApp StoreData updated 2026-08-05.